15
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1943 |
ML347
LDN 193719 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
ML347 (LDN 193719) 是一种选择性的 ALK1/ALK2 抑制剂,它们的 IC50 分别为 46/32 nM,比对 ALK3 的抑制性高 300 倍。 | |||
T1944 |
LDN-214117
|
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
LDN214117 是一种高效的 ALK2 选择性抑制剂(IC50:22nM),也是一种 BMP6 抑制剂(IC50:100nM),对ALK5抑制力弱100倍。 | |||
T78128 |
GALK1-IN-1
|
Others | Others |
GALK1-IN-1(化合物4)是一种IC50为4.2129 μM的半乳糖激酶抑制剂。 | |||
T76858 |
Ascrinvacumab
PF-03446962 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
Ascrinvacumab (PF-03446962) 是一种针对 ALK-1 的高效人源化 IgG2 单克隆抗体。Ascrinvacumab 对人 ALK1 的 Kd 值为 7 nM。Ascrinvacumab 对 TGF-β 有抑制作用,可用于研究肝细胞癌 (HCC)。 | |||
T1914 |
K02288
K 02288 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
K 02288是骨形态发生蛋白 (BMP) I 型受体抑制剂,能够抑制 ALK1 (IC50:1.8nM)、ALK2 (IC50:1.1nM)、ALK6 (IC50:6.4nM)。对 ALK3 和 ALK6 的抑制稍弱,IC50在 5-34 nM 之间。 | |||
T1900 |
LDN-212854
LDN212854,BMP Inhibitor III |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
LDN-212854 (BMP Inhibitor III) 是一种新型BMP 抑制剂,抑制 ALK2 的IC50=1.3 nM,比对ALK1,ALK3,ALK4和ALK5的抑制性高2,66,1641和7135倍。 | |||
T1935 |
LDN193189
LDN-193189,DM-3189,LDN 193189 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
LDN193189 (LDN-193189) 是BMPI 型受体的选择性抑制剂,能够抑制 ALK2 (IC50:5 nM)、 ALK3 (IC50:30 nM)。对 ALK4、ALK5 和 ALK7 的作用效果弱 (IC50≥500 nM)。 | |||
T35348 |
LDN-193189 2HCl
LDN-193189 2HCl,DM-3189 2HCl |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
LDN-193189 2HCl (DM-3189 2HCl) 是一种选择性 BMP 信号抑制剂,对ALK1,ALK2,ALK3和ALK6有抑制作用,在激酶实验中显示的 IC50 分别为 0.8 nM、0.8 nM、5.3 nM 和 16.7 nM。LDN-193189 2HCl 在C2C12细胞中对BMP I 型受体ALK2和ALK3的转录活性有抑制作用,IC50分别为5 nM 和30 nM,作用于BMP 比作用于TGF-β选择性高200倍。 | |||
T1942 |
DMH-1
DMH1 |
ALK; Autophagy; TGF-beta/Smad | Angiogenesis; Autophagy; Stem Cells; Tyrosine Kinase/Adaptors |
DMH-1 是一种选择性 BMP 抑制剂,对 ALK1、ALK2、ALK3和 ALK6的 IC50值分别为 27、107.9、<5和 47.6 nM。 | |||
T73490 |
MU1700
|
||
MU1700 是一种具有口服活性的、强效的 ALK1/2抑制剂,IC50分别为 13 nM 和 6 nM,其具有细胞膜通透性以及高脑渗透性。 | |||
T70176 | P7170 | ||
P7170 is an anti-cancer agent active as an mTORC1/C2 and activin receptor-like kinase 1 (ALK1) inhibitor. | |||
T6158 |
LDN-193189 HCl
LDN193189 Hydrochloride |
ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
LDN-193189 HCl (LDN193189 Hydrochloride) 是一种选择性 BMP I 型受体激酶抑制剂。 | |||
T74660 |
M4K2234
|
||
M4K2234 (compound 26b) 是 ALK2的抑制剂。M4K2234 抑制 ALK2和 ALK5的 IC50值分别为 5 和 2144 nM。M4K2234 可用作 ALK1和 ALK2蛋白激酶的化学探针。M4K2234 可用于癌症的研究。 | |||
T21637 |
SB-505124 hydrochloride
|
||
SB-505124 hydrochloride 是TGF-βI 型受体(ALK4,ALK5,ALK7) 的选择性抑制剂,对 ALK4,ALK5 的IC50值分别为 129 nM 和 47 nM,对 ALK1,2,3 或 6 无作用。 | |||
T35896 |
AZ 12799734
AZ12799734 |
ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
AZ 12799734 是一种具有口服活性、选择性和有效性的 TGFBR1和 ALK5 双重抑制剂,对 BMP 和 TGFβ 有抑制作用,可用于研究肿瘤。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01168 |
ALK-1 Protein, Human, Recombinant (His)
ALK1,ALK-1,activin A rec... |
Human | HEK293 Cells |
ALK-1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 12.3 kDa and the accession number is A0A0S2Z310. | |||
TMPK-00924 |
SLPI Protein, Mouse, Recombinant (hFc)
WAP4,BLPI,SLPI,HUSI-1,HUSI,MPI,ALP,WFDC4,ALK |
Mouse | HEK293 Cells |
Elafin and SLPI (secretory leucocyte protease inhibitor) have multiple important roles both in normal homoeostasis and at sites of inflammation. These include antiprotease and antimicrobial activity as well as modulation of the response to LPS (lipopolysaccharide) stimulation. Elafin and SLPI are members of larger families of proteins secreted predominantly at mucosal sites, and have been shown to be modulated in multiple pathological conditions. SLPI Protein, Mouse, Recombinant (hFc) is express... | |||
TMPY-00662 |
ALK-1 Protein, Mouse, Recombinant (His & hFc)
AI115505,AI427544,activin A receptor type ... |
Mouse | HEK293 Cells |
ALK-1 Protein, Mouse, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 39 kDa and the accession number is Q61288. | |||
TMPK-00767 |
SLPI Protein, Human, Recombinant (hFc)
WFDC4,HUSI,SLPI,WAP4,MPI,BLPI,ALK1,HUSI- |
Human | HEK293 Cells |
Elafin and SLPI (secretory leucocyte protease inhibitor) have multiple important roles both in normal homoeostasis and at sites of inflammation. These include antiprotease and antimicrobial activity as well as modulation of the response to LPS (lipopolysaccharide) stimulation. Elafin and SLPI are members of larger families of proteins secreted predominantly at mucosal sites, and have been shown to be modulated in multiple pathological conditions. SLPI Protein, Human, Recombinant (hFc) is express... | |||
TMPY-00650 |
ALK-1 Protein, Human, Recombinant (hFc)
SKR3,ORW2,TSR-I,ALK1,activin A receptor ty... |
Human | HEK293 Cells |
ALK-1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 37.4 kDa and the accession number is A0A0S2Z310. | |||
TMPJ-00304 |
ALK-1 Protein, Mouse, Recombinant (hFc)
TSR-I,Serine/threonine-protein kinase receptor R3,ALK |
Mouse | HEK293 Cells |
Activin Receptor-Like Kinase 1 (ALK-1) is a type I cell-surface receptor for the TGF-β superfamily of ligands, which mediates signaling of BMP9 (bone morphogenetic protein) and BMP10. ALK1 signaling is necessary for angiogenesis during embryogenesis, wound healing, and tumor growth. ALK-1 has a high degree of similarity in serine-threonine kinase subdomains, a glycine and serine rich region preceding the kinase-domain, and a C-terminal tail with other activin receptor-like kinase proteins. ALK-1... | |||
TMPY-04464 |
GALK1 Protein, Human, Recombinant (His & GST)
galactokinase 1,HEL-S-19,GALK,GK<... |
Human | Baculovirus Insect Cells |
Galactokinase, also known as Galactose kinase, GALK and GALK1, is a protein which belongs to theGHMP kinase family and GalK subfamily. Galactokinase / GALK1 is a major enzyme for galactose metabolism. Galactokinase (GALK) deficiency is an autosomal recessive disorder characterized by elevation of blood galactose concentration and diminished galactose-1-phosphate, leading to the production of galactitol. Defects in GALK1 are the cause of galactosemia II ( GALCT2 ) which II is an autosomal ... | |||
TMPJ-00997 |
GALK1 Protein, Human, Recombinant (His)
Galactokinase,Galactose Kinase,GALK1,G... |
Human | E. coli |
Galactokinase belongs to the GHMP kinase family and GalK subfamily. Galactokinase is more important to the galactose metabolism pathway. It modifies galactose to create a similar molecule called Galactose-1-Phosphate.Thus, a series of additional steps converts Galactose-1-Phosphate to another simple sugar Glucose, which is the main energy source for most cells. Galactokinase deficiency results in Galactosemia II, an autosomal recessive deficiency characterized by congenital cataracts during infa... |